7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Heart & Metabolism

How Do Pacemakers, CRT and Defibrillators Support a Failing Heart? Device Therapy Explained

24 min read
How Do Pacemakers, CRT and Defibrillators Support a Failing Heart? Device Therapy Explained

Key Takeaways

  • A normal ejection fraction is roughly 55 to 70 percent, and an EF of 35 percent or lower is the threshold at which guidelines begin considering an implantable defibrillator or CRT.
  • A conventional pacemaker only prevents slow heart rates; it does not strengthen a weak ventricle and offers no benefit when electrical timing is normal.
  • CRT works by pacing both ventricles simultaneously, and it helps most in people with a wide QRS and left bundle branch block on their ECG.
  • An ICD protects against sudden cardiac arrest but does nothing for breathlessness or fatigue, which is why some people reasonably choose CRT pacing without shock capability.
  • Guidelines usually ask for a period on optimized heart failure medicines, commonly around three months, before a device is implanted, because ejection fraction often improves on treatment.
  • After a pacemaker, CRT or ICD, people are generally advised to avoid heavy lifting and vigorous arm movement for about a month while the leads settle into the heart wall.
Quick Answer

Heart failure device therapy uses small implanted electrical devices to support a weakened heart. Pacemakers keep the heart from beating too slowly, cardiac resynchronization therapy (CRT) re-times the two pumping chambers so they contract together, and implantable defibrillators (ICDs) deliver a shock to stop life-threatening rhythms. Mechanical pumps (LVADs) are reserved for advanced cases. Devices add to, and never replace, heart failure medicines and lifestyle care.

The echo report said 30 percent. Her cardiologist drew a little heart on the back of a lab slip, shaded the left side, and said the word she had been dreading: device. On the drive home she rehearsed the questions she wished she had asked. Is it a pacemaker? Does it shock you? Will it fix the number?

Those three questions sit at the center of almost every conversation about heart failure device therapy, and the honest answers are: sometimes, sometimes, and not in the way most people imagine. A device does not repair muscle. What it can do is correct a slow rhythm, coordinate a heart whose two pumping chambers have fallen out of step, or stand guard against the sudden electrical storms that make a weakened heart dangerous.

This guide walks through what each device actually does, who tends to be offered one, what the weeks afterward look like, and where the popular assumptions go wrong.

What does heart failure device therapy actually mean?

Heart failure is not a heart that has stopped. It is a heart that cannot pump strongly enough, or fill easily enough, to meet the body’s needs, so fluid backs up in the lungs and legs and the person tires quickly. Medicines that ease the heart’s workload remain the foundation of treatment, and most people with heart failure never need an implant at all.

Device therapy enters the picture when the weakness is severe enough, or the heart’s electrical system disordered enough, that medicines alone leave a gap. Four families of devices do this work, and they solve four different problems:

  • A pacemaker is a small generator with thin wires (leads) that sends tiny electrical pulses to keep the heart from beating too slowly.
  • Cardiac resynchronization therapy (CRT), sometimes called a biventricular pacemaker, paces both lower chambers so they squeeze at the same moment instead of one after the other.
  • An implantable cardioverter-defibrillator (ICD) watches every beat and delivers rapid pacing or a shock if it detects a rhythm that could cause cardiac arrest.
  • A left ventricular assist device (LVAD) is a mechanical pump, connected to the heart through surgery, that takes over much of the left ventricle’s pumping when it is failing badly.

The first three sit under the skin near the collarbone and are placed in a cardiac catheterization lab, usually with sedation rather than full anesthesia. The LVAD is open-heart surgery and belongs to advanced heart failure care. Grouping them under one phrase can make them sound interchangeable. They are not, and understanding which problem each one addresses is the single most useful thing a patient can bring to the consultation.

How bad is an ejection fraction of 35?

Ejection fraction, usually shortened to EF, is the percentage of blood the left ventricle pushes out with each beat. The American Heart Association describes a normal range as roughly 55 to 70 percent; a healthy heart never empties completely, so 100 percent is not the goal and never has been.

Patient in hospital bed discussing meal with healthcare provider: How bad is an ejection fraction of 35?

An EF of 35 percent means the ventricle is ejecting about a third of what it holds. That is well below normal and places a person firmly in the category doctors call heart failure with reduced ejection fraction. Yet 35 is also a threshold that appears repeatedly in device decisions, and this is where the number needs context rather than alarm. According to the AHA, an EF of 35 percent or lower is associated with a higher risk of life-threatening irregular heartbeats, which is precisely why guidelines use it as one of the criteria for considering an ICD, and, when the electrical signal is also delayed, for CRT.

Two things soften the picture. First, EF is a snapshot, not a verdict. It commonly improves after several months on well-adjusted heart failure medicines, which is one reason clinicians often wait before implanting anything. Second, EF measures squeeze, not symptoms. Some people with an EF of 35 climb stairs comfortably; others with a higher EF struggle. Doctors weigh both together, along with how far the electrical signal has slowed on the ECG and what caused the weakness in the first place.

So the fair answer to “how bad is 35?” is: serious enough to deserve full treatment and close follow-up, common enough that a well-worn pathway exists, and changeable enough that the number itself should never be the only thing a person hears in the room.

How does a pacemaker for heart failure work?

A standard pacemaker does one job: it prevents the heart from beating too slowly. Two parts make that possible. The generator, a metal case about the size of a large coin, holds the battery and a tiny computer. One or two leads run from the generator through a vein into the heart, where their tips rest against the muscle and both sense the heart’s own signals and deliver a pulse when needed.

The device does not fire constantly. It listens. When the heart produces a beat on its own, the pacemaker stays quiet. When a beat is late or missing, a pulse smaller than a static spark nudges the muscle to contract. People do not feel it.

Where does this fit in heart failure? A slow heart rate can itself cause or worsen heart failure, because output equals the amount pumped per beat multiplied by the number of beats. When the heart’s natural pacemaker or the wiring between the chambers wears out, restoring a normal rate can lift symptoms considerably. Some heart failure medicines also slow the heart, and a pacemaker can allow those medicines to be continued when a slow pulse would otherwise limit them.

What a conventional pacemaker cannot do is strengthen a weak ventricle. If a person’s only problem is a low ejection fraction with normal electrical timing, a simple pacemaker offers no benefit, and in some situations pacing a single chamber for years can actually worsen coordination. That is why clinicians who suspect a device may be needed long-term often think ahead to whether a resynchronization system, described next, is the better fit from the start.

Battery life for pacemakers is commonly quoted by the Mayo Clinic as around 5 to 15 years depending on how much the device is used, after which the generator is replaced in a shorter procedure.

How does CRT re-time a heart that beats out of step?

Picture two rowers who should pull together but one drags half a stroke behind. The boat still moves, just badly. In some people with heart failure the electrical signal that tells the left ventricle to contract travels slowly through damaged tissue, so the left wall squeezes noticeably later than the right or later than the septum between them. On an ECG this shows up as a wide QRS complex, the spike that represents the ventricles depolarizing. The result is wasted effort: blood sloshes within the chamber instead of leaving it cleanly.

Doctor consulting patient about healthy eating with salad: How does CRT re-time a heart that beats out of step?

Cardiac resynchronization therapy corrects the timing. It uses a pacemaker generator with an extra lead. One lead sits in the right ventricle as usual; a second is threaded through a small vein on the back surface of the heart to reach the left ventricle. The device then paces both walls within milliseconds of each other so they contract in unison. Doctors call the mistimed pattern dyssynchrony and the fix resynchronization.

For the right person the effect is mechanical and immediate: a more efficient squeeze, a better ejection fraction over time, less shortness of breath, and often the ability to do more. The Mayo Clinic notes CRT is generally considered for people with moderate to severe heart failure whose lower chambers are not beating in sync despite medicines.

Honesty demands a caveat. Not everyone benefits. A meaningful minority of people show little or no improvement even when the device is working perfectly, and predicting who will respond remains imperfect. People with the widest electrical delay and a specific pattern called left bundle branch block tend to gain most; those with narrow QRS complexes generally do not, and guidelines steer away from CRT in that group. That is why the ECG, not just the echo, drives this decision.

How does an implantable defibrillator stop a dangerous rhythm?

A weak heart is an electrically irritable heart. Scar tissue and stretched muscle create pathways where a rhythm can spiral into ventricular tachycardia (very fast beats that pump poorly) or ventricular fibrillation (chaotic quivering that pumps nothing). Either can cause sudden cardiac arrest within minutes. The National Heart, Lung, and Blood Institute describes the ICD as a device designed to detect exactly these rhythms and restore a normal beat.

Mechanically it resembles a pacemaker with a thicker generator and a heavier-duty lead. The difference lies in what it can deliver. Most of the time it does nothing but monitor. If the rate climbs into a dangerous zone, the device first tries anti-tachycardia pacing: a brief burst of rapid pulses that can interrupt the circuit without the person noticing. If that fails or the rhythm is fibrillation, it charges and delivers a shock through the heart. People who have received one often describe it as a hard thump or a kick in the chest; it lasts a fraction of a second.

Two designs exist. The transvenous ICD has leads inside the heart and can also pace for slow rhythms. The subcutaneous ICD places its lead entirely under the skin along the ribs, avoiding the veins and heart chambers, but it cannot provide long-term pacing and is chosen when that is not needed.

What an ICD does not do is treat heart failure symptoms. It will not ease breathlessness or improve ejection fraction. Its purpose is protection against a specific catastrophic event. This distinction matters when people weigh the decision, because the trade-off is a lifetime of carrying a device, occasional inappropriate shocks, and periodic generator changes against protection from a risk they cannot feel day to day.

CRT vs ICD: what is the difference, and why do some people get both?

The two are often confused because both live near the collarbone and both use leads, yet they answer different questions. CRT asks: can we make this heart pump more efficiently? The ICD asks: can we catch a lethal rhythm before it kills? Because many people with a low ejection fraction have both problems, a combined device called CRT-D pairs resynchronization pacing with defibrillator capability in one generator. A CRT without the shock function is called CRT-P.

Device Main purpose Treats symptoms? Prevents sudden arrest? Typical placement
Pacemaker Prevents slow heart rate Yes, if slowness is the cause No Under skin near collarbone; leads via vein
CRT-P Coordinates both ventricles Often, in people with wide QRS No Same, with third lead to left ventricle
ICD Detects and stops dangerous fast rhythms No Yes Same; subcutaneous version avoids veins
CRT-D Both coordination and shock protection Often Yes Same as CRT-P, larger generator
LVAD Mechanically pumps for the left ventricle Yes, in advanced failure No (separate ICD usually kept) Open-heart surgery; external controller and batteries

Choosing between CRT-P and CRT-D is one of the more nuanced calls in cardiology. A person whose main risk is death from worsening pump failure rather than sudden arrhythmia, or who is older with other serious illnesses, may be offered pacing alone. Someone younger with scar from a prior heart attack is more likely to be offered the defibrillator as well. The American Heart Association’s overview of devices frames these as individualized decisions made with the treating cardiologist, and that framing is accurate: the same echo and ECG can reasonably lead two informed patients to different devices depending on their goals.

Who is heart failure device therapy usually for, and who is usually asked to wait?

Guidelines from the American Heart Association and the European Society of Cardiology converge on a similar set of conditions before an ICD or CRT is offered. The person typically has an ejection fraction of 35 percent or lower, has symptoms despite treatment, and has been on well-adjusted heart failure medicines for a period, commonly around three months, so that the heart has had a fair chance to recover on its own. For CRT specifically, the ECG must show a wide QRS, with the strongest recommendation reserved for left bundle branch block.

Life expectancy matters too. Because the benefit of an ICD accrues over years, most guidelines suggest it for people expected to live at least a year with reasonable quality of life. This is not a judgment about worth; it is about whether a device is likely to help rather than add burden.

People commonly asked to wait fall into several groups:

  • Those newly diagnosed whose ejection fraction may still rise on medicines.
  • Those recovering from a recent heart attack, where early ICD implantation has not shown benefit in trials and guidelines advise reassessment after a waiting period.
  • Those with reversible causes, such as a very fast atrial rhythm or a recently opened coronary artery, where fixing the cause may fix the pump.
  • Those with a narrow QRS, for whom CRT is not recommended.

Age alone is not a reason to withhold a device. Frailty, kidney function, other illnesses, and above all the person’s own priorities shape the discussion more than the number of birthdays. Some people, after understanding what an ICD does, decide they would rather not have shocks in their final years and choose CRT-P or medicines alone. That is a legitimate choice, and a good team will present it as one. The decision, in every case, rests with the person and the clinicians who know their full history.

What actually happens during the implant procedure?

For pacemakers, CRT and transvenous ICDs the procedure follows a similar script in a cardiac catheterization or electrophysiology lab. The person lies on a table under an X-ray camera, awake but sedated, with a local anesthetic numbing the area below the collarbone. An intravenous line delivers sedation and antibiotics to reduce infection risk.

The doctor makes a small incision, usually a few centimeters long, and creates a pocket under the skin or beneath the chest muscle for the generator. A vein beneath the collarbone is entered with a needle, and the leads are threaded through it toward the heart while the X-ray shows their position. Placing a lead in the right atrium or right ventricle is relatively direct. The left ventricular lead for CRT is the fiddly part: it must be steered into a branch of the coronary sinus, a vein on the heart’s back surface, and anatomy varies enough that this step can add time or, rarely, prove impossible, in which case a surgical alternative is discussed.

Once the leads are in place the team tests them, checking that they sense the heart’s signals and pace it reliably. For an ICD, some centers test the shock function; many now skip this step unless there is a specific reason. The leads are connected to the generator, which is tucked into the pocket, and the incision is closed with stitches or glue.

The Mayo Clinic describes CRT implantation as typically taking a few hours, with many people going home the same day or after one night. People often report the sedation makes the experience hazy rather than painful, with soreness afterward similar to a deep bruise. Subcutaneous ICDs involve a different incision along the side of the chest, and LVAD surgery, covered below, is an entirely different undertaking.

What do the first days and weeks after a device usually look like?

The first night brings a chest X-ray to confirm lead position and a device check to make sure settings are right. Discomfort at the pocket site is normal; over-the-counter pain relief is usually enough, but the team will advise what suits the individual’s other medicines.

The wound needs to stay clean and dry while it heals. Teams generally ask people not to soak the area in a bath or pool for a period after the procedure and to watch for redness, warmth, swelling or drainage. A small bruise is expected; a growing, tense lump is not and should be reported.

The most important instruction concerns the arm on the device side. Leads take time to settle into the heart wall, and vigorous movement early on can shift them. The Mayo Clinic advises avoiding heavy lifting and vigorous exercise for about a month; many teams specifically ask people not to raise the arm above shoulder height during that window. Everyday movement, walking and gentle use of the arm are encouraged, because a completely frozen shoulder creates its own problems.

Driving rules vary by country and state and differ between pacemakers and defibrillators; the NHS, for instance, sets a minimum period off driving after pacemaker implantation and longer restrictions after an ICD shock. The right answer is the one the local licensing authority and the treating team give.

A follow-up visit is typically scheduled within the first few weeks to inspect the wound and fine-tune the device. Many systems are then linked to a bedside monitor that transmits data automatically, so the device is checked without a visit. Batteries do not need thought for years, but the person will learn the sound or vibration the device makes when it is time for a replacement.

Symptom improvement after CRT, when it comes, tends to be gradual over weeks to months as the heart adapts to coordinated beating.

When is an LVAD heart pump considered?

A left ventricular assist device is a different order of intervention. It is a small mechanical pump, implanted in the chest through open-heart surgery, that draws blood from the left ventricle and pushes it into the aorta, doing much of the work the ventricle can no longer manage. A cable called the driveline exits through the skin of the abdomen and connects to an external controller and batteries the person carries in a bag or vest.

The Mayo Clinic describes three broad reasons a person might be offered one. The first is as a bridge to transplant: keeping someone alive and stronger while waiting for a donor heart. The second is as destination therapy, meaning long-term support for people who are not candidates for transplant. The third is as a bridge to decision or recovery, when the team needs time to see whether the heart will improve.

Who reaches this point? People with advanced heart failure whose symptoms persist at rest or with minimal activity despite medicines and, often, despite CRT, and whose kidneys, liver and other organs are beginning to suffer from poor blood flow. It is a treatment for a small proportion of people with heart failure, chosen after a detailed evaluation by an advanced heart failure team.

Life with an LVAD requires commitment. Blood-thinning medicines are needed to prevent clots in the pump, the driveline site needs daily care to prevent infection, and batteries must be swapped and charged without fail. Swimming is not possible. Many people, however, describe regaining the ability to walk, travel locally and take part in family life in ways that had become impossible. The pump does not correct rhythm problems, so an ICD is usually retained alongside it.

What are the risks, and what are the alternatives?

Every implant carries risk, and a fair explainer names them without inflating them. For pacemakers, CRT and ICDs the main early complications, described across Mayo Clinic and NHLBI patient material, are bleeding or bruising at the pocket, infection, a punctured lung (pneumothorax) during vein access, and a lead that shifts and needs repositioning. Serious complications are uncommon, but they occur, and the CRT left ventricular lead adds a small additional risk of vein injury.

Longer-term issues include lead fracture or insulation failure, pocket infection that can require removal of the whole system, and, for ICDs, inappropriate shocks triggered by a fast but benign rhythm or by electrical noise. Inappropriate shocks are painful and frightening, and modern programming has reduced them, but they have not disappeared. Generator replacements every several years each carry a fresh, smaller infection risk.

LVAD risks are of a different scale: bleeding, stroke, driveline infection, pump thrombosis and right-heart failure are all recognized, which is why the decision involves weeks of evaluation.

Alternatives depend on the problem. For a low ejection fraction without electrical delay, optimized medicines remain the primary treatment, and the combination of several drug classes has shifted outcomes substantially over the past two decades. For people who qualify for an ICD but do not want one, continuing medicines with clear conversations about goals is a reasonable path, and a wearable external defibrillator vest can provide temporary protection during a period of uncertainty. For advanced heart failure, transplant assessment, palliative approaches focused on comfort, or a decision not to escalate are all legitimate options that good teams raise openly.

What the evidence does not support is delaying medicines in favor of a device, or viewing any implant as a substitute for the daily work of managing salt, fluid, weight and activity.

What people often get wrong about heart failure devices

“The device fixes the heart.” It does not repair muscle. A pacemaker corrects rate, CRT corrects timing, an ICD corrects rhythm emergencies. Ejection fraction may improve after CRT because the heart works more efficiently, but the underlying disease is still there and still needs medicines.

“There is a best device for heart failure.” Searches for this phrase are common, and the premise is mistaken. The right device depends on rate, QRS width, cause of weakness, other illnesses and personal goals. A CRT-D is not “better” than a pacemaker; it is for a different person.

“An ICD will make me feel better.” It will not change breathlessness or energy. Its value is invisible protection against sudden arrest. Some people feel reassured by that; others feel burdened. Both reactions are reasonable.

“Once I have a device, medicines are optional.” Trials establishing device benefit enrolled people already on full medical therapy. Devices were tested as an addition, never as a replacement.

“You can beat heart failure.” Heart failure is managed, not conquered. Many people live well for years, and some see their ejection fraction return to near normal, but the language of winning sets up a sense of failure when symptoms fluctuate, as they do.

“Microwaves and phones will stop my pacemaker.” Household appliances are safe. Keeping a phone or a strong magnet a short distance from the generator is prudent advice, but ordinary life does not require avoidance.

“A shock means the device is malfunctioning.” Usually the opposite: a shock most often means it detected something dangerous and acted. Every shock does warrant a call to the team, both to check the rhythm and to review medicines.

“I am too old.” Age is not a criterion in guidelines; overall health and preference are.

Questions to ask your care team

The consultation moves fast and the vocabulary is unfamiliar. Bringing written questions changes the conversation from a briefing into a discussion. These are the ones that tend to unlock the most useful answers:

  • Which specific problem is this device meant to solve for me: slow rate, mistimed contraction, dangerous rhythms, or pump failure?
  • What does my ECG show about electrical delay, and does that make CRT more or less likely to help me?
  • Have my medicines been fully adjusted, and is there a reason to wait and repeat the echo before deciding?
  • If you are recommending a defibrillator, what is my estimated risk of a dangerous rhythm, and how does that compare with the risk of inappropriate shocks?
  • Would a CRT-P without shock capability be a reasonable option for me, and why or why not?
  • What symptoms should improve, what will not change, and over what timeframe?
  • What are the most likely complications in the first month, and how will I recognize them?
  • How will the device be monitored, and who do I call when something feels wrong?
  • How long is the battery expected to last, and what does replacement involve?
  • What are the driving and travel rules where I live?
  • If my heart recovers, could the device ever be turned off or removed?
  • What happens to the device if my health declines and I no longer want shocks?

The last question is uncomfortable and important. Defibrillators can be deactivated without surgery, and many people want to know that option exists before they agree to an implant. A team that welcomes the question is a team thinking about the whole person.

Write the answers down, or ask permission to record them. A good cardiologist will not be offended, and the details will matter later.

When to call your doctor

Most recovery after a device is uneventful, but some signs should never wait for the next scheduled visit.

Call emergency services immediately if a person with an ICD receives more than one shock in a short period, receives a shock and does not recover quickly, collapses, or loses consciousness. Do the same for sudden severe chest pain, difficulty breathing that comes on abruptly, or signs of stroke such as facial drooping, arm weakness or slurred speech. For someone with an LVAD, any alarm from the controller that the person cannot resolve, or a sudden change in the pump’s sound, is an emergency handled by the LVAD team’s hotline and emergency services together.

Contact the device clinic or cardiologist the same day for a single ICD shock, even if the person feels fine afterward; the team will read the stored rhythm and decide whether anything needs to change. Do the same for redness, warmth, swelling, increasing pain or any fluid leaking from the incision, which can signal infection; for a fever without another obvious cause in the weeks after implantation; for the device becoming visible through thinning skin; for new hiccups or twitching in the chest or abdomen that could indicate a lead stimulating the diaphragm; or for a return of the dizziness or fainting the device was meant to prevent.

Worsening heart failure also deserves a prompt call rather than watchful waiting. Weight rising quickly over a few days, new swelling in the ankles or abdomen, needing more pillows to breathe at night, or breathlessness with activities that were manageable last week are all reasons to phone. Catching fluid buildup early often means an adjustment rather than an admission, and the treating team, not this article, decides what that adjustment should be.

Frequently asked questions

How bad is an ejection fraction of 35?

An ejection fraction of 35 percent is well below the normal range of roughly 55 to 70 percent and indicates heart failure with reduced ejection fraction. It is also the level at which guidelines begin considering an ICD, because the risk of dangerous rhythms rises. Yet EF often improves after months on adjusted medicines, and symptoms do not always track the number, so it is a starting point for treatment rather than a fixed verdict.

What is the best device for heart failure?

There is no single best device. Each type solves a different problem: pacemakers treat slow rates, CRT corrects mistimed contraction in people with a wide QRS, ICDs guard against sudden cardiac arrest, and LVADs mechanically pump for the left ventricle in advanced disease. The right choice depends on your ECG, echocardiogram, cause of heart weakness, other conditions and personal goals, and it is made together with your cardiology team.

How much does an LVAD device cost?

This article does not quote prices, because costs vary enormously by health system, insurance arrangement and what is bundled into the figure, and any number would mislead more than inform. Hospitals offering LVAD therapy typically have financial counselors who can explain coverage for your specific situation. Your advanced heart failure team is the right place to raise the question early, before the medical evaluation is complete.

How do you beat heart failure?

Heart failure is managed rather than defeated, and framing it as a battle to win can set people up for disappointment when symptoms fluctuate. Effective management combines several classes of medicines adjusted over time, attention to salt and fluid, regular activity, treating causes such as blocked arteries or high blood pressure, and devices when criteria are met. Many people live well for years, and some see their ejection fraction recover substantially.

What is the difference between CRT vs ICD?

CRT is a pacing therapy that coordinates the two lower chambers so they contract together, improving pumping efficiency and often easing symptoms. An ICD is a protective device that detects dangerous fast rhythms and stops them with rapid pacing or a shock; it does not improve symptoms. Many people with a low ejection fraction have both needs, so a combined CRT-D device is common, while CRT-P provides pacing alone.

Does a pacemaker for heart failure improve ejection fraction?

A conventional pacemaker does not improve ejection fraction; it prevents the heart from beating too slowly, which helps only if slowness is contributing to symptoms. Cardiac resynchronization therapy, a specialized pacemaker with an extra lead to the left ventricle, can improve ejection fraction over months in people whose ventricles are contracting out of sync. Whether that applies to you depends on the width and pattern of the QRS on your ECG.

How long does recovery take after a pacemaker or ICD?

Most people go home the same day or after one night, according to the Mayo Clinic, and return to light daily activity within days. Soreness at the implant site usually settles over a week or two. The main restriction is avoiding heavy lifting and vigorous arm movement on the device side for about a month while the leads embed in the heart wall. Driving rules vary by location and device type, so follow your team’s guidance.

What does an ICD shock feel like?

People who have experienced one commonly describe a sudden hard thump or kick in the chest lasting a fraction of a second, sometimes with a brief moment of confusion. Anti-tachycardia pacing, which the device tries first, is usually not felt at all. A single shock after which you feel well should prompt a same-day call to your device clinic; repeated shocks or a shock followed by collapse is an emergency.

Who is a candidate for an LVAD heart pump?

An LVAD is considered for people with advanced heart failure whose symptoms persist at rest or with minimal activity despite full medicines and, often, despite CRT. The Mayo Clinic describes its use as a bridge to transplant, as long-term destination therapy for those not eligible for transplant, or as a bridge while the team assesses recovery. Candidacy requires detailed evaluation of other organs, support at home and the person’s own goals.

Can a heart failure device be turned off later?

Yes. An ICD’s shock function can be deactivated without surgery using the programmer at a device clinic, and this is a recognized option for people whose health declines and who no longer want shocks. Pacing functions are generally left on because turning them off can cause symptoms. Many people find it reassuring to discuss this possibility before implantation, and a good care team will welcome the conversation.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 15, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.